|
(Health-NewsWire.Net, October 13, 2021 )
Market Overview
An autoimmune disorder is a disorder that occurs when the body’s immune system is unable to differentiate between its own cells and foreign cells due to which the body mistakenly attacks normal cells. The symptoms of this disorder include abdominal pain, recurring fever, swollen glands, fatigue, and joint pain, swelling, and skin problems.
View full report: https://bit.ly/3lCa6bo
Market Dynamics
The global autoimmune treatment market growth is driven by the rise prevalence of autoimmune disease coupled with growing patient awareness levels accounted for the major driver of this market.
The rising prevalence of autoimmune diseases is expected to drive the growth in the forecast period
The major factor attributing to the growth of the autoimmune treatment market is a surge in the prevalence of autoimmune diseases. According to NIH (National Institutes of Health) up to 23.5 million Americans have an autoimmune disease and its prevalence is increasing. Scientists have identified 80-100 various autoimmune diseases and assume at least 40 other diseases of having an autoimmune basis.
The other factors that play a major role in taking the autoimmune treatment market to the next level are increasing investments in research and development of drugs for autoimmune diseases, technological advancements in diagnosis, and awareness of the therapy. Rising government initiatives for regulating these diseases are also helping the growth of the market.
Market Segmentation:
By Drug Class
• Anti-Inflammatory
• Anti-Hyperglycemic
• NSAIDs
By Indication
• Rheumatic Disease
• Diabetes
• Multiple Sclerosis
By Distribution Channel
• Hospital Pharmacy
• Pharmacy Stores
Download free sample: https://bit.ly/3AzRIUP
Geographical Analysis
North America region holds the largest market share global autoimmune treatment market
North America region is dominating the global autoimmune treatment market accounted for the largest market share in 2020. This is due to factors such as the rising incidence and prevalence of autoimmune diseases such as arthritis, lupus, multiple sclerosis, in the country. In the North American region, the United States holds the largest market share due to growing personal expenditure on healthcare.
The healthcare commerce in the province is developing at a quick stride, resulting in the progress of the market. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase the market growth.
Competitive Landscape
The autoimmune treatment market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Abbott Laboratories, Amgen, Johnson & Johnson, Eli Lilly & Co., Pfizer, Roche, AstraZeneca Plc, Bristol-Myers Squibb Co. GlaxoSmithKline Plc, and Lupin Limited among others.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the autoimmune treatment market globally.
Related Topic's
Immunosuppressants Drugs Market, Allergy Immunotherapies Market, Thrombocytopenia Management Market, Systemic Lupus Erythematosus Market, Systemic Sclerosis Market
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
|
